APA (7th ed.) Citation

Marques, E., Pfohl, M., Auclair, A., Jamwal, R., Barlock, B. J., Sammoura, F. M., . . . Slitt, A. L. (2020). Perfluorooctanesulfonic acid (PFOS) administration shifts the hepatic proteome and augments dietary outcomes related to hepatic steatosis in mice. Toxicology & Applied Pharmacology, 408, N.PAG. https://doi.org/10.1016/j.taap.2020.115250

Chicago Style (17th ed.) Citation

Marques, Emily, Marisa Pfohl, Adam Auclair, Rohitash Jamwal, Benjamin J. Barlock, Ferass M. Sammoura, Michael Goedken, Fatemeh Akhlaghi, and Angela L. Slitt. "Perfluorooctanesulfonic Acid (PFOS) Administration Shifts the Hepatic Proteome and Augments Dietary Outcomes Related to Hepatic Steatosis in Mice." Toxicology & Applied Pharmacology 408 (2020): N.PAG. https://doi.org/10.1016/j.taap.2020.115250.

MLA (9th ed.) Citation

Marques, Emily, et al. "Perfluorooctanesulfonic Acid (PFOS) Administration Shifts the Hepatic Proteome and Augments Dietary Outcomes Related to Hepatic Steatosis in Mice." Toxicology & Applied Pharmacology, vol. 408, 2020, p. N.PAG, https://doi.org/10.1016/j.taap.2020.115250.